Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SONIBEC: Tailored Schedule of Sonidegib in Locally Advanced Basal Cell Carcinomas
NCT04806646Phase 2Active, not recruiting
- Sponsor
- Gruppo Oncologico Nord Ovest
- Start
- Jan 2021
- Primary completion
- Dec 2024
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of sonidegib in basal cell carcinoma (BCC), sponsored by Gruppo Oncologico Nord Ovest. Started Jan 2021; status: active, not recruiting.
02
Drugs
sonidegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT04806646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04806646.